Anales de la RANM
38 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 FIBRA ALIMENTARIA Y DIABETES TIPO 2 Pérez-Jiménez J An RANM. 2025;142(01): 30 - 40 AGRADECIMIENTOS La autora agradece su apoyo al Foro de Jóvenes Investigadores Teófilo Hernando (Fundación Teófilo Hernando/ Real Academia Nacional de Medicina de España). DECLARACIÓN DE TRANSPARENCIA Los autores/as de este artículo declaran no tener ningún tipo de conflicto de intereses respecto a lo expuesto en el presente trabajo. BIBLIOGRAFÍA 1. Commission Directive 2008/100/EC of 28 October 2008 amending Council Directive 90/496/EEC on nutrition labelling for foods- tuffs as regards recommended daily allowan- ces, energy conversion factors and defini- tions. Official J European Union. 2008; 51: 9–12. 2. Cummings JH, Engineer A. Denis Burkitt and the origins of the dietary fibre hypothesis. Nutr Res Rev. 2018;31(1):1-15.doi: 10.1017/ S0954422417000117 3. Global Burden of Disease (2017) Diet Colla- borators. Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;393(10184):1958-1972. doi: 10.1016/S0140-6736(19)30041-8 4. Bingham SA, Day NE, Luben R et al. Euro- pean Prospective Investigation into Cancer and Nutrition. Dietary fibre in food and pro- tection against colorectal cancer in the Euro- pean Prospective Investigation into Cancer and Nutrition (EPIC): an observational stu- dy. Lancet. 2003;361(9368):1496-1501. doi: 10.1016/s0140-6736(03)13174-1 5. Sun H, Saeedi P, Karuranga S et al. IDF Dia- betes Atlas: Global, regional and country- level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi: 10.1016/j.dia- bres.2021.109119 6. Davies MJ, Aroda VR, Collins BS et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Stu- dy of Diabetes (EASD). Diabetes Care. 2022;45(11):2753-2786. doi: 10.2337/dci22- 0034 7. Srour B, Fezeu LK, Kesse-Guyot E et al. Ul- traprocessed Food Consumption and Risk of Type 2 Diabetes Among Participants of the NutriNet-Santé Prospective Cohort. JAMA Intern Med. 2020;180(2):283-291. doi: 10.1001/jamainternmed.2019.5942 8. Meyer KA, Kushi LH, Jacobs DR Jr, Slavin J, Sellers TA, Folsom AR. Carbohydrates, die- tar y fiber, and incident type 2 diabetes in ol- der women. Am J Clin Nutr. 2000;71(4):921- 930. doi: 10.1093/ajcn/71.4.921 9. InterAct Consortium. Dietar y fibre and incidence of type 2 diabetes in eight Eu- ropean countries: the EPIC-InterAct Study and a meta-analysis of prospective studies. Diabetologia. 2015;58(7):1394-1408. doi: 10.1007/s00125-015-3585-9 10. Yao B, Fang H, Xu W et al. Dietar y fiber in- take and risk of type 2 diabetes: a dose-res- ponse analysis of prospective studies. Eur J Epidemiol. 2014;29(2):79-88. doi: 10.1007/ s10654-013-9876-x 11. Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L. Carbohydrate quality and human health: a series of sys- tematic reviews and meta-analyses. Lancet. 2019;393(10170):434-445. doi: 10.1016/ S0140-6736(18)31809-9 12. Partula V, Deschasaux M, Druesne-Pecollo N et al. Associations between consump- tion of dietar y fibers and the risk of car- diovascular diseases, cancers, type 2 dia- betes, and mortality in the prospective NutriNet-Santé cohort. Am J Clin Nutr. 2020;112(1):195-207. doi: 10.1093/ajcn/ nqaa063 13. Reynolds AN, Akerman AP, Mann J. Die- tar y fibre and whole grains in diabetes management: Systematic review and meta- analyses. PLoS Med. 2020;17(3):e1003053. doi: 10.1371/journal.pmed.1003053 14. Veluvali A, Snyder M. Dietar y fiber defi- cienc y in individuals with metabolic syn- drome: a review. Curr Opin Clin Nutr Me- tab Care. 2023;26(6):564-569. doi: 10.1097/ MCO.0000000000000971 15. Robertson MD, Wright JW, Loizon E et al. Insulin-sensitizing effects on muscle and adipose tissue after dietar y fiber intake in men and women with metabolic syndrome. J Clin Endocrinol Metab. 2012;97(9):3326- 3332. doi: 10.1210/jc.2012-1513 16. Halajzadeh J, Milajerdi A, Reiner Ž et al. Effects of resistant starch on glycemic control, serum lipoproteins and systemic inf lammation in patients with metabolic syndrome and related disorders: A syste- matic review and meta-analysis of rando- mized controlled clinical trials. Crit Rev Food S ci Nutr. 2020;60(18):3172-3184. doi: 10.1080/10408398.2019.1680950 17. Juhász AE, Greff D, Teutsch B et al. Galac- tomannans are the most effective soluble dietar y fibers in type 2 diabetes: a syste- matic review and network meta-analysis. Am J Clin Nutr. 2023;117(2):266-277. doi: 10.1016/j.ajcnut.2022.12.015 18. Baars DP, Fondevila MF, Meijnikman AS, Nieuwdorp M. The central role of the gut microbiota in the pathophysiology and ma- nagement of type 2 diabetes. Cell Host Mi- crobe. 2024;32(8):1280-1300. doi: 10.1016/j. chom.2024.07.017
RkJQdWJsaXNoZXIy ODI4MTE=